ISRCTN88796215已完成未知
A randomised trial of adjuvant 5-fluorouracil, leucovorin and radiotherapy in colorectal adenocarcinoma
Wyeth-Lederle Ltd (UK)0 个研究点目标入组 0 人开始时间: 2002年8月19日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Aged 18 to 80 years
- •2. World Health Organisation (WHO) performance status zero to two
- •3. Histological proof of colorectal adenocarcinoma
- •4. The entire colorectum must be visualised pre- or postoperatively to exclude synchronous carcinoma
- •5. Potentially curative surgery
- •6. Adjuvant treatment to be initiated within six weeks of surgery
- •7. Adequate bone marrow, renal and hepatic function
排除标准
- •No previous malignancy except carcinoma in situ of cervix or basal cell carcinoma of skin
研究者
相似试验
已完成
不适用
A randomised trial of infusional 5-fluorouracil and concomitant radiotherapy in locally advanced rectal cancer, comparing three and six months of infusional 5-fluorouracilCancer of rectumCancerISRCTN93845533The Royal Marsden NHS Foundation Trust (UK)
已完成
不适用
Phase II randomized trial comparing 5-fluorouracil in continuous infusion and cisplatin (FP) versus leucovorin, bolus 5-fluorouracil and cisplatin (FLP) in metastatic gastric, pancreatic and oesophageal cancerMetastatic gastric, pancreatic and oesophageal cancerOesophagealCancerISRCTN05842222French Federation of Digestive Cancers (Fédération Francophone de la Cancérologie Digestive [FFCD]) (France)232
已完成
2 期
Randomized phase II/III study of 5-fluorouracil /l-leucovorin vs. 5-fluorouracil /l-leucovorin plus paclitaxel in gastric cancer with severe peritoneal metastasis (JCOG1108/WJOG7312G, abbreviation:GC_FL/FLTAX_P2/3)Gastric cancerJPRN-UMIN000010949Japan Clinical Oncology Group (JCOG)330
未知
不适用
Randomized clinical trial on the efficacy of 5-fluorouracil(5-FU) ointment on the outer and middle ear cholesteatomaJPRN-UMIN000024217agasaki University hospital54
进行中（未招募）
1 期
Phase 1b trial of 5-fluorouracil, leucovorin, irinotecan in combination with temozolomide (FLIRT) and bevacizumab for the first-line treatment of patients with MGMT silenced, microsatellite stable metastatic colorectal cancer.metastatic colorectal cancerMedDRA version: 27.0Level: LLTClassification code: 10052362Term: Metastatic colorectal cancer Class: 10029104MedDRA version: 20.0Level: SOCClassification code: 10029104Term: Neoplasms benign malignant and unspecified (incl cysts and polyps) Class: 2CTIS2024-515580-64-00Fondazione IRCCS Istituto Nazionale Dei Tumori18